The effects of a probiotic mixture (PRO), supplemented with either galacto-oligosaccharide (GOS) or polydextrose (PDX), on cell numbers of lactic acid bacteria (LAB) and bifidobacteria (BIF) were studied in conventional rats and healthy human subjects. In rats the baseline BIF cell numbers were below the detection limit and were increased by the 2-week GOSPRO intervention. In contrast baseline LAB numbers in rats were high and not affected by the treatments. The human study consisted of two independent but concurrent trials; both started with PRO followed by GOSPRO or PDXPRO periods. In the human subjects variation in numbers of BIF and LAB were high. The GOSPRO group exhibited high counts of faecal LAB and BIF at the start and showed little or no effects of the interventions. In contrast, the PDX group had low faecal LAB and BIF numbers at the start and clearly increased cell numbers of BIF after the PDXPRO period, and LAB after the PRO and PDXPRO period, compared with the run-in period. We propose here that responses to pro-and prebiotics are dependent on baseline numbers of LAB and/or BIF, and that the conventional rat model does not predict well the treatment responses in humans. The survival of PRO was presumably enhanced by the use of prebiotic supplementation and advocates the use of particular combinations of pro-and prebiotics.
Probiotics: Prebiotics: Polydextrose: Galacto-oligosaccharidesLactobacillus and Bifidobacterium species are the most widely used probiotics and their health effects have been reviewed 1 -3 . Probiotics generally do not colonise the gut permanently because the exogenous bacteria are outcompeted by the endogenous microbiota, which is better adapted to the prevailing conditions in the gastrointestinal tract 4 . Prebiotics (typically non-digestible carbohydrates) may give a competitive advantage to the live-fed probiotic bacteria in the gastrointestinal tract and may also have direct effects on the resident microbial community in the large intestine 5 . Non-digestible carbohydrates can modify both the composition and metabolism of the intestinal microbiota and thereby the immunological responses of the gut 5,6 . Thus far, the most studied prebiotics are fructo-oligosaccharides 7 -10 . In the present study two different types of approved food-grade non-digestible carbohydrates were included in the trial: partially fermentable polydextrose (PDX) (Litessew Ultra) and completely fermentable galacto-oligosaccharide (GOS)-containing syrup (Elix'or). Litessew Ultra is a randomly bonded polymer of dextrose containing minor amounts of sorbitol (6 %) and citric acid. The GOS syrups typically contain a mixture of oligosaccharides (60 %) and lactose (20 %), glucose (19 %) and galactose (1 %). Previous studies have shown that both PDX and GOS can improve bowel function in humans but GOS, however, increases gastrointestinal symptoms such as flatulence and abdominal pain at lower dosages than PDX 11,12 . Intake of PDX more than 50 g/d may cause diarrhoea 11 . In studies of intestinal microbio...